Safety, Toxicity, and Side Effects of G
Results from a recent study suggest that tirzepatide may be more effective in helping people who have obesity or overweight lose weight than semaglutide
It is also important to understand that stopping treatment suddenly without maintaining lifestyle changes may contribute to weight regain in some individuals
Warning signs include trembling, sweating, confusion, palpitations, dizziness, or extreme tiredness
Additionally, the funds will accelerate the development of its portfolio of oral and injectable formulations, strengthening its global expansion in the treatment of obesity and metabolic diseases
most vials and prefilled syringes are expected to remain viable for 30 to 90 days, so the pharmacy-assigned beyond-use date should govern use